American Transplant Congress 2026 presentations

American Transplant Congress (ATC)

 📍 Boston, MA, USA

 📅 June 20-24, 2026

 We’re proud to present the following abstracts:

📆 June 20

 🔹 𝗥𝗲𝗷𝗲𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗜𝗻𝗷𝘂𝗿𝘆 𝗥𝗲𝗱𝘂𝗰𝗲 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗖𝘆𝘁𝗼𝗺𝗲𝘁𝗿𝘆 𝗘𝘀𝘁𝗶𝗺𝗮𝘁𝗲𝘀 𝗼𝗳 𝗧𝗿𝗲𝗴 𝗖𝗼𝗺𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻 𝗶𝗻 𝗞𝗶𝗱𝗻𝗲𝘆 𝗧𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁 𝗕𝗶𝗼𝗽𝘀𝗶𝗲𝘀

👤 Patrick Gauthier | 5:45 pm | Exhibit Hall

📆 June 21

 🔹 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗦𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝗰𝗲 𝗼𝗳 𝗦𝘂𝗯𝘁𝗵𝗿𝗲𝘀𝗵𝗼𝗹𝗱 𝗧 𝗖𝗲𝗹𝗹-𝗠𝗲𝗱𝗶𝗮𝘁𝗲𝗱 𝗥𝗲𝗷𝗲𝗰𝘁𝗶𝗼𝗻-𝗥𝗲𝗹𝗮𝘁𝗲𝗱 𝗟𝗲𝘀𝗶𝗼𝗻𝘀 (𝗶- 𝗮𝗻𝗱 𝘁-𝗦𝗰𝗼𝗿𝗲𝘀) 𝗶𝗻 𝗞𝗶𝗱𝗻𝗲𝘆 𝗧𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁 𝗕𝗶𝗼𝗽𝘀𝗶𝗲𝘀

👤 Katelynn Madill-Thomsen | 2:45 pm | Exhibit Hall

 🔹 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗰𝘆𝘁𝗼𝗺𝗲𝘁𝗿𝘆 𝗮𝗻𝗱 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗳𝗲𝗮𝘁𝘂𝗿𝗲𝘀 𝗼𝗳 𝗕𝗞 𝗻𝗲𝗽𝗵𝗿𝗼𝗽𝗮𝘁𝗵𝘆 𝗶𝗻 𝗸𝗶𝗱𝗻𝗲𝘆 𝘁𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁 𝗯𝗶𝗼𝗽𝘀𝗶𝗲𝘀

👤 Martina Mackova  | 2:45 pm | Exhibit Hall

 🔹 𝗧𝗵𝗲 𝗣𝗼𝘀𝘁-𝗧𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁 𝗣𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 𝗼𝗳 𝗢𝗹𝗱 𝗗𝗲𝗰𝗲𝗮𝘀𝗲𝗱 𝗗𝗼𝗻𝗼𝗿 𝗞𝗶𝗱𝗻𝗲𝘆𝘀 𝗖𝗮𝗻𝗻𝗼𝘁 𝗕𝗲 𝗥𝗲𝗹𝗶𝗮𝗯𝗹𝘆 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗲𝗱

👤 Martina Mackova  | 2:45 pm | Exhibit Hall

 🔹 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗙𝗲𝗹𝘇𝗮𝗿𝘁𝗮𝗺𝗮𝗯 𝗼𝗻 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗖𝘆𝘁𝗼𝗺𝗲𝘁𝗿𝘆 𝗟𝗲𝘂𝗸𝗼𝗰𝘆𝘁𝗲 𝗘𝘀𝘁𝗶𝗺𝗮𝘁𝗲𝘀 𝗶𝗻 𝗕𝗶𝗼𝗽𝘀𝗶𝗲𝘀 𝘄𝗶𝘁𝗵 𝗔𝗕𝗠𝗥

👤 Patrick Gauthier | 3:45 pm | 253BC, Level 2

📆 June 22

 🔹 𝗜𝗻 𝗵𝗲𝗮𝗿𝘁 𝘁𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁𝘀, 𝗗𝗦𝗔-𝗻𝗲𝗴𝗮𝘁𝗶𝘃𝗲 𝗮𝗻𝗱 𝗗𝗦𝗔-𝗽𝗼𝘀𝗶𝘁𝗶𝘃𝗲 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝘆-𝗺𝗲𝗱𝗶𝗮𝘁𝗲𝗱 𝗿𝗲𝗷𝗲𝗰𝘁𝗶𝗼𝗻 𝗵𝗮𝘃𝗲 𝘀𝗶𝗺𝗶𝗹𝗮𝗿 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗳𝗲𝗮𝘁𝘂𝗿𝗲𝘀, 𝘁𝗶𝗺𝗶𝗻𝗴, 𝗱𝗱-𝗰𝗳𝗗𝗡𝗔 𝗮𝗻𝗱 𝗹𝗲𝘂𝗸𝗼𝗰𝘆𝘁𝗲 𝗰𝗼𝗺𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻: 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗧𝗿𝗶𝗳𝗲𝗰𝘁𝗮-𝗛𝗲𝗮𝗿𝘁 𝘀𝘁𝘂𝗱𝘆

👤 Katelynn Madill-Thomsen | 8:15 am | Ballroom

 🔹 𝗖𝗼𝗺𝗽𝗮𝗿𝗶𝗻𝗴 𝗛𝗶𝘀𝘁𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗔𝗰𝘂𝘁𝗲 𝗖𝗲𝗹𝗹𝘂𝗹𝗮𝗿 𝗥𝗲𝗷𝗲𝗰𝘁𝗶𝗼𝗻 𝗚𝗿𝗮𝗱𝗲 𝟭𝗥 𝘄𝗶𝘁𝗵 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗠𝗶𝗰𝗿𝗼𝘀𝗰𝗼𝗽𝗲® 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗦𝘆𝘀𝘁𝗲𝗺 𝗖𝗹𝗮𝘀𝘀𝗶𝗳𝗶𝗲𝗿𝘀 𝗮𝗻𝗱 𝗗𝗼𝗻𝗼𝗿-𝗗𝗲𝗿𝗶𝘃𝗲𝗱 𝗖𝗲𝗹𝗹-𝗙𝗿𝗲𝗲 𝗗𝗡𝗔 (𝗱𝗱-𝗰𝗳𝗗𝗡𝗔) 𝗟𝗲𝘃𝗲𝗹𝘀

👤 Martina Mackova | 2:45 pm | Exhibit Hall

 🔹 𝗜𝗻𝗰𝗿𝗲𝗺𝗲𝗻𝘁𝗮𝗹 𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗲 𝗶𝗻 𝗗𝗼𝗻𝗼𝗿-𝗗𝗲𝗿𝗶𝘃𝗲𝗱 𝗖𝗲𝗹𝗹-𝗙𝗿𝗲𝗲 𝗗𝗡𝗔 (𝗱𝗱-𝗰𝗳𝗗𝗡𝗔) 𝗮𝗻𝗱 𝗥𝗶𝘀𝗸 𝗼𝗳 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗥𝗲𝗷𝗲𝗰𝘁𝗶𝗼𝗻 𝗶𝗻 𝗛𝗲𝗮𝗿𝘁 𝗧𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁 (𝗛𝗧) 𝗥𝗲𝗰𝗶𝗽𝗶𝗲𝗻𝘁𝘀

👤 Martina Mackova | 2:45 pm | Exhibit Hall

🔹 𝗧𝗵𝗲 𝗟𝗲𝘂𝗸𝗼𝗰𝘆𝘁𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 𝗗𝗶𝘀𝘁𝗶𝗻𝗴𝘂𝗶𝘀𝗵𝗶𝗻𝗴 𝗧𝗖𝗠𝗥, 𝗔𝗕𝗠𝗥, 𝗮𝗻𝗱 𝗔𝗰𝘂𝘁𝗲 𝗜𝗻𝗷𝘂𝗿𝘆 𝗶𝗻 𝗛𝗲𝗮𝗿𝘁 𝗧𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁 𝗕𝗶𝗼𝗽𝘀𝗶𝗲𝘀

👤 Patrick Gauthier | 2:45 pm | Exhibit Hall

📆 June 22

 🔹 𝗜𝗻 𝗛𝗲𝗮𝗿𝘁 𝗧𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁𝘀 𝗖𝘂𝗿𝗿𝗲𝗻𝘁 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱-𝗼𝗳-𝗖𝗮𝗿𝗲 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗧𝗖𝗠𝗥 𝗮𝗻𝗱 𝗔𝗕𝗠𝗥 𝗶𝘀 𝗢𝗳𝘁𝗲𝗻 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 𝗣𝗲𝗿𝘀𝗶𝘀𝘁𝗲𝗻𝗰𝗲 𝗼𝗳 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗥𝗲𝗷𝗲𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗘𝗹𝗲𝘃𝗮𝘁𝗲𝗱 𝗱𝗱-𝗰𝗳𝗗𝗡𝗔

👤 Martina Mackova | 9:54 am | 254AB, Level 2

 🔹 𝗖𝘂𝗿𝗿𝗲𝗻𝘁 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱-𝗼𝗳-𝗖𝗮𝗿𝗲 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗧𝗖𝗠𝗥 𝗮𝗻𝗱 𝗔𝗕𝗠𝗥 𝗶𝗻 𝗞𝗶𝗱𝗻𝗲𝘆 𝗧𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗶𝘀 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 𝗣𝗲𝗿𝘀𝗶𝘀𝘁𝗲𝗻𝗰𝗲 𝗼𝗳 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗥𝗲𝗷𝗲𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗘𝗹𝗲𝘃𝗮𝘁𝗲𝗱 𝗱𝗱-𝗰𝗳𝗗𝗡𝗔

👤 Philip Halloran | 10:18 am | 254AB, Level 2